Daewha to patent for arterial embolus preparations against cancer.

Published: 2005-06-21 06:58:00

Updated: 2005-06-21 06:58:00

Daewha Pharmaceutical company announced on June 16 about the patent registration of "the preparations and its manufacturing process of combomed Pacliataxel and its w/o type of emulsion for the use of chemical embolus"

"Arterial embolus technology" is a local tumor removal approach. It is for a...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK